BLOOD PRODUCTS ADVISORY COMMITTEE
March 15, 2001
Briefing Information
Comparative sensitivity of HBsAg and HBV NAT Tests pdf
Implementation of NAT for HCV and HIV; Testing, Donor and Product Management pdf
Algorithms pdf
AABB 53rd Annual Meeting: Lack of Evident to Support the Presence of NAT Inhibitors in Donor Specimens, November 7, 2000 pdf
AABB 53rd Annual Meeting: Multiplex NAT Reactive Donor Specimens Tested Non-Reactive in Discriminatory Assays are Negative for HIV-1 and HCV RNA, November 7, 2000 pdf
Diversion of Initial Volume of Collected Blood to a Separate Container; consideration of benefits and design of collection system, Jaro Votal, MD, PhD, CBER pdf
Experience on Whole Blood Bacterial Contamination, Cees L. van der Poel MD PhD, Sanquin Blood Supply Foundation, The Netherlands pdf
Statement of the American Association of Blood Banks: Blood Bags for Diversion of the Initial Collection, Louis Katz, MD pdf
Statement of the American Association of Blood Banks: HBV NAT vs. HBsAG, Louis Katz, MD pdf
Statement of the American Association of Blood Banks: Implementation of NAT for HBV and HIV: Donor and Product Management, Louis Katz, MD pdf
Comparative Sensitivity of HBV NAT vs. HbsAg, Statement of America's Blood Centers, Celso Bianco, MD pdf
Implementation of NAT for HCV and HIV: Testing, Donor and Product Management, Statement of America's Blood Centers, Celso Bianco, MD pdf
Blood Bags for Diversion of Initial Collection, Statement of America's Blood Centers, Celso Bianco, MD pdf
Extending the Ban on British Donors regarding vCJD/BSE to all Western European Countries is not justified, Paul F W Strengers, MD, CLB Blood Bank, The Netherlands pdf
PRISM HBsAg Performance Relative to HBV NAT, Mary C Kuhns PhD, Abbott Laboratories pdf
BACTIVAM for diversion of the initial collection, Macopharma experience, Guillaume de Saint Martin pdf
Blood Bags for Diversion of the Initial Collection, Mark Popovsky, MD, Haemonetics Corporation pdf
Results on HBV DNA positive samples using HBsAg screening tests and mini-pool NAT screening in Hokkaido, Paul Holland, MD, Sacremento Blood Center pdf